✦ LIBER ✦

THE IN VIVO ACTIVATION OF THE FAS DEATH RECEPTOR PATHWAY IN TRANSITIONAL CELL CARCINOMA OF THE BLADDER FOLLOWING TREATMENT WITH MITOMYCIN-C

✍ Scribed by H.F. O'Kane; C. Watson; P. Hyland; R. Johnston; K. Williamson

Book ID: 118647229
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 69 KB
Volume: 5
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(06)60074-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitomycin c in the treatment of metastat

Mitomycin c in the treatment of metastatic transitional cell carcinoma of urinary bladder

✍ K. Early; E. G. Elias; A. Mittelman; D. Albert; G. P. Murphy 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

Mitomycin C was administered t o 21 patients with metastatic transitional cell carcinoma of the urinary bladder. O f these, 19 patients were evaluable. Objective response occurred in f o u r patients, or 21 %. Hemopoietic depression was common and was dose related. Nephrotoxicity related t o the dr

Efficacy of intravesical mitomycin C in

Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder

✍ Abraham Pavlotsky; Abraham Eidelman; Frida Barak; Haim Alon; Dr. Yoav Horn 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB 👁 1 views

We treated 47 patients with recurrent transitional cell carcinoma of the bladder with intravesical chemotherapy. Twenty milligrams of mitomycin C per treatment was introduced 7 days after transurethral resection (TUR) or diagnostic cystoscopy, and was repeated at 2-week intervals for five times foll

Lntravesical Instillation of Mitomycin C

Lntravesical Instillation of Mitomycin C in the Prophylactic Treatment of Recurring Superficial Transitional Cell Carcinoma of the Bladder

✍ M. DEVONEC; R. BOUVIER; J. SARKISSIAN; O. BENDIMERAD; A. GELET; J. M. DUBERNARD 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Interferons Modify in Vitro Proliferatio

Interferons Modify in Vitro Proliferation of Human Bladder Transitional Cell Carcinoma in the Presence of Doxorubicin and Mitomycin C

✍ Okamoto, E.; Kinne, R.K.H.; Sokeland, J. 📂 Article 📅 1996 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 435 KB

Long-term follow-up of patients with sup

Long-term follow-up of patients with superficial transitional cell carcinoma of the urinary bladder treated by intravesical mitomycin C

✍ Abraham Pavlotsky; Abraham Eidelman; Frida Barak; Natalio Walach; Dr. Yoav Horn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 1 views

Transferrin Receptor Activity as a Marke

Transferrin Receptor Activity as a Marker in Transitional Cell Carcinoma of the Bladder

✍ I. BAşAR; A. AYHAN; K. BiRCAN; A. ERGEN; ¸. TAşAR 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB